Impilo completed an investment in Avia Pharma.

Impilo, a Nordic private investment company, completed an investment in Avia Pharma, a Swedish pharmaceutical platform. Financial terms were not disclosed. “Impilo is very excited to partner with Avia management and the co-founders, Jacob Calmvik and Jostein Lønberg. We have followed Avia’s growth journey closely and look forward to supporting the Company in its effort to build a leading platform in the OTC/Rx space,” Carolina Oscarius Dah, Impilo Partner.